O
OmniAb Inc
NASDAQ:OABI
OmniAb Inc
NASDAQ:OABI
Price:
4.5 USD
-0.88%
Market Closed
Updated:
May 9, 2024
Section:
Relative Value
The Relative Value of one OABI stock under the Base Case scenario is 4.45 USD. Compared to the current market price of 4.5 USD, OmniAb Inc is Overvalued by 1%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
OABI
Relative Value
Base Case
4.45
USD
Overvaluation 1%
O
Valuation Multiples
Multiples Across Competitors
OABI Competitors Multiples
OmniAb Inc Competitors
OmniAb Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
O
|
OmniAb Inc
NASDAQ:OABI
|
525.9m USD | 15.4 | -10.4 | -8.8 | -6.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
223.4B USD | 5.2 | 37.2 | 22.9 | 33.6 | |
| US |
|
Danaher Corp
NYSE:DHR
|
186.1B USD | 4.3 | 23 | 16.7 | 20.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
42.5B USD | 6.3 | 34.4 | 27.4 | 32.9 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
38B CHF | 5.7 | 58 | 19.9 | 29.2 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.5B USD | 2.8 | 30.6 | 16.6 | 25.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 15 | 64.8 | 34.2 | 49.2 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.7B USD | 7.3 | 35.3 | 24.5 | 27.2 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.8B USD | 9.1 | 46.8 | 32.4 | 39.3 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26B USD | 3.2 | 38 | 17.1 | 26.3 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19.1B EUR | 7 | 75.2 | 32.4 | 53.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
